DOCK3 and Stroke: MoCA (Nasreddine et al., 2005) has been suggested as a feasible screening tool for detecting cognitive impairment following stroke (Horstmann et al., 2014; Julayanont & Nasreddine, 2017; Munthe‐Kaas et al., 2021), where key advantages are short administration time and multiple cognitive domains of assessment (Burton & Tyson, 2015; Stolwyk Renerus et al., 2014).